Partnering for success in life sciences | Nuvolo Case Study

Nuvolo, a cloud-based software company serving life sciences, needed to deliver GxP-compliant asset management solutions without diverting internal resources or rebuilding its platform. Sware provided the Res_Q Platform and expert support to implement a fully digital validation workflow. As a result, Nuvolo achieved end-to-end paperless workflows, improved risk assurance for customers, and reallocated seven engineers who previously handled validation. Jason Siegrist, Nuvolo's CISO, stated: "Our system is completely digitally mapped. Sware provided invaluable support by bringing deep industry knowledge." The partnership lets Nuvolo meet audit requirements and scale GxP-compliant solutions as customer needs evolve.

Sware is a GxP validation platform whose entire commercial focus is life sciences — used specifically to validate AI/ML systems' explainable, traceable decisions for regulatory scrutiny.

This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.